Medizinische Universität Graz - Research portal
-
Univ.-Prof. Dr.med. Dr.med.habil Peter Schlenke
- Department of Blood Group Serology and Transfusion Medicine
- Head and Chair of Department
- Head of Research Unit
- FE Hematopoietic stem cell differentiation
- EMail: peter.schlenke(at)medunigraz.at
- Tel: +43/316/385/83067
- https://www.medunigraz.at/universitaetskliniken/blutgruppenserologie-und-transfusionsmedizin
- MEDonline-Visitenkarte
- Externe ID's
- ORCiD: 0000-0002-3271-3836
Statistik Austria, science classification
- Transfusion medicine - (302082)
Scientific Expertise
- Hemotherapy
- Transfusion Medicine
- (Non-) Hematopetic Stem Sells
- Induced Pluripotent Stem Sells
- Pathogen Inactivation
- Immunogenetics
- Blood safety
- Patient Blood Management
- CAR-T-Cell Therapy
Curr. Vitae
| 2025 -2028 | Board Director of the German Society of Transfusion Medicine and Immunohematology |
| 2020 -2026 | Vice President, President, Past President of the Austrian Society for Blood Group Serology, Transfusion Medicine, Regenerative Medicine and Immunogenetics |
| 2017 | Member of the Blood Commission of the Ministry for Health and Women |
| 2014 | Editor-in-Chief, Transfusion Medicine and Hemotherapy |
| 2014 | Full Professor and Medical Director of the Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Austria |
| 2014 | Chair of the KAGes advisory board "Blood banking affairs" |
| 2011 -2014 | Member of the Stem Cell Network North-Rhine Westphalia Research Group “In-vitro Generation of Blood Cells” |
| 2010 -2015 | JACIE Inspector (Joint Accreditation Committee of the International Society of Cell Therapy and the European Group of Bone Marrow Transplantation) |
| 2010 -2018 | Council Member “European School of Transfusion Medicine” |
| 2009 -2014 | Associate Editor, Transfusion Medicine and Hemotherapy |
| 2008 -2014 | Deputy Medical Director, Institute of Transfusion Medicine and Transplant Immunology (Director: Prof. W. Sibrowski), University of Muenster Qualified Person for Collection, Testing and Manufacturing of Blood, Head of Research and Development (Stem Cells / Cell Therapeutics) |
| 2006 -2008 | Chair of the Section Stem Cell Transplantation & Cell Therapy German Society of Transfusion Medicine and Immunohematology |
| 2005 -2008 | Project Manager of the Clinical Study “Safety and Efficacy of Pathogen Inactivated Platelets” (292-P-NIV) Cerus Corporation, Concord, CA, USA |
| 2002 -2002 | “Habilitation” in the field of immunology and transfusion medicine “Characterization, Processing and Transplantation of Peripheral Blood Stem Cells” |
| 1998 -2008 | Board Certification Transfusion Medicine |
| 1998 -2008 | Head of Blood Donation Center and GMP-Manufacturing Site Medical University of Luebeck Responsible Person for Regulatory Affairs |
| 1996 -1997 | Internship, Department of Hematology and Oncology (Prof. T. Wagner), Medical University of Luebeck |
| 1994 -1998 | Internship, Institute of Immunology & Transfusion Medicine (Prof. H. Kirchner), Medical University of Luebeck |
| 1993 -1994 | Resident at the Institute of Immunology & Transfusion Medicine University of Luebeck |
| 1993 -1994 | Resident at the Institute of Immunology & Transfusion Medicine University of Luebeck (Chairman: Prof. H. Kirchner) |
| 1993 -1993 | Doctoral thesis at the Surgical clinic of the Georg August University Goettingen “Diagnosis, Therapy and Prognosis of the Pancreas Carcinoma” |
| 1986 -1992 | Study of human medicine at the Georg August University Goettingen |
Awards
| 2017 | Großes goldenes Ehrenzeichen des Landesverbandes Steiermark, ÖRK |
| 2015 | Philip Levine Preis der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie |
Appointments/Memberships in Professional Societies
| 2022 -2024 | Präsident der Österreichischen Fachgesellschaft für Blutgruppenserologie, Transfusionsmedizin, Regenerative Medizin und Immungenetik (ÖGBT) Präsident |
| 2020 -2022 | Vizepräsident der Österreichischen Fachgesellschaft für Blutgruppenserologie, Transfusionsmedizin, Regenerative Medizin und Immungenetik (ÖGBT) Vizepräsident |
| 2017 -2021 | Blutkommission des Bundesministerium für Gesundheit und Frauen Mitglied |
Editorial board appointments for scientific journals
| 2014 -2023 | TRANSFUSION MEDICINE AND HEMOTHERAPY: Editor in Chief |
| 2009 -2014 | TRANSFUSION MEDICINE AND HEMOTHERAPY: Associate Editor |
Reviewer for scientific journals
| 2020 -2021 | HEALTHCARE |
| 2020 -2021 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2008 -2020 | TRANSFUSION |
| 2020 -2020 | ANAESTHESIST |
| 2008 -2018 | TRANSFUSION MEDICINE AND HEMOTHERAPY |
| 2016 -2018 | CELL AND TISSUE BANKING |
| 2018 -2018 | HAEMATOLOGICA |
| 2017 -2017 | JOURNAL OF CRITICAL CARE |
| 2017 -2017 | STEM CELLS AND DEVELOPMENT |
| 2014 -2014 | CELL AND TISSUE BANKING |
Expert for appointment/habilitation procedures
| 2023 | Berufung: Gutachter: Medizinische Fakultät der Universität Würzburg W2&/W3 Professur |
| 2022 | Berufung: Gutachter: Ludwig-Maximilians-Universität München Professur |
| 2021 | Berufung: Gutachter: Medizinische Universität Wien Professur |
| 2021 | Berufung: Gutachter: Rheinische Friedrich-Wilhelms-Universität Bonn W2-Professur |
| 2020 | Habilitation: Gutachter: Paracelsus Medizinische Privatuniversität Salzburg |
Reviewer/Expert funding organizations
| 2016 -2021 | Jubiläumsfond der Österr. Nationalbank, Österreich - Austria |
| 2015 -2015 | Bundesministerium für Wissenschaft und Forschung - Austria |
Organizer of scientific conferences, Chairs
| 2022 | 29. Jahrestagung der Deutschen Gesellschaft für Immungenetik (DGI) Organisator |
| 2017 | Jahrestagung der Österreichischen Gesellschaft für Blutgruppenserologie und Transfusionsmedizin (ÖGBT) Chair |